Hide metadata

dc.date.accessioned2013-03-12T09:09:44Z
dc.date.available2013-03-12T09:09:44Z
dc.date.issued2008en_US
dc.date.submitted2008-09-01en_US
dc.identifier.citationRead, Matthew Lovell. Synthesis of Pyrimidines as Potential Tuberculosis Drugs. Masteroppgave, University of Oslo, 2008en_US
dc.identifier.urihttp://hdl.handle.net/10852/12832
dc.description.abstract6-Aryl-9-substituted benzylpurines as antimycobacterial agents have been previously studied in our group.1-5 The structural activity relationship (SAR) of antimycobacterial purines is generally well understood5 (Figure 1, compound 1). We have decided, after exploring the SAR of intact purines to investigate the activity of pyrimidine analogs of 6-aryl-9-substituted benzylpurines antimycobacterial agents. Herein we discuss the synthesis of 6-aryl-4-substituted benzylpyrimidines (Figure 1, compound 2) and antimycobacterial activity of these compounds found to date.eng
dc.language.isoengen_US
dc.subjectpyrimidiner tuberkulose medisineren_US
dc.titleSynthesis of Pyrimidines as Potential Tuberculosis Drugsen_US
dc.typeMaster thesisen_US
dc.date.updated2009-04-16en_US
dc.creator.authorRead, Matthew Lovellen_US
dc.subject.nsiVDP::440en_US
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft.au=Read, Matthew Lovell&rft.title=Synthesis of Pyrimidines as Potential Tuberculosis Drugs&rft.inst=University of Oslo&rft.date=2008&rft.degree=Masteroppgaveen_US
dc.identifier.urnURN:NBN:no-20050en_US
dc.type.documentMasteroppgaveen_US
dc.identifier.duo83431en_US
dc.contributor.supervisorLise-Lotte Gundersenen_US
dc.identifier.bibsys092076254en_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/12832/1/MatthewxReadxmastersxthesis.pdf


Files in this item

Appears in the following Collection

Hide metadata